Kerry serves as the VP and head of the portfolio management office for Mariana Oncology, a Novartis company. She has nearly 25 years of biotech and pharma experience, spanning from rare disease research benchwork through global program leadership.

Prior to joining Mariana Oncology, Kerry held program management leadership positions at Dragonfly Therapeutics and Bluebird Bio. She was an executive director of program management and chief of staff to the CSO at ImmunoGen (IMGN) and served as a program and alliance manager across multiple research and early development programs. Kerry spent 15 years at Genzyme and Sanofi genzyme in research and R&D program management in therapeutic areas of rare disease, orthopedics, and immune-mediated diseases, including serving as a global program head for a Ph1 OA Pain program.

Kerry has an MS in biochemistry and molecular biology from the University of Massachusetts at Amherst and an MBA from Babson College. She is also a certified Insights Discovery® facilitator.